The Bad Obstetric History (BOH) panel test is a comprehensive diagnostic blood evaluation recommended for women who have experienced recurrent pregnancy losses, such as consecutive spontaneous miscarriages, stillbirths, or early neonatal deaths.
This panel primarily investigates underlying medical triggers by screening for chronic infections—such as TORCH agents—autoimmune and blood-clotting disorders like antiphospholipid syndrome, and hormonal imbalances including thyroid dysfunction. By precisely identifying these root causes, healthcare providers can design targeted treatment plans to support safer, healthier outcomes in future pregnancies.

The Blood Toxic Element Profile Test is a comprehensive diagnostic panel designed to measure the levels of hazardous heavy metals and toxic substances circulating in the bloodstream. This specialized screening evaluates exposure to harmful elements such as lead, mercury, arsenic, cadmium, and aluminum, which can accumulate from environmental pollution, occupational hazards, or dietary sources. Elevated concentrations of these heavy metals can cause severe systemic damage affecting neurological, renal, and cardiovascular functions. By accurately quantifying these toxic loads, healthcare providers can identify acute or chronic poisoning, monitor detoxification treatments, and implement targeted interventions.

The beta-2 microglobulin (B2M) test measures the amount of a small protein found on the surface of most cells in your body. Small amounts naturally shed into your blood and urine, but high levels can mean certain cells are turning over too quickly or your immune system is working overtime. Doctors usually order this test to help diagnose, monitor, or check the severity of blood cancers like multiple myeloma, lymphoma, and certain leukemias. It can also help evaluate kidney damage or inflammatory conditions, giving your healthcare team important insights into your overall health and treatment progress.

A **Basic Arthritis Profile for Male** is a targeted blood panel designed to evaluate systemic inflammation and identify markers associated with various arthritic conditions. This profile typically includes tests such as Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) to detect generalized inflammatory responses, along with Rheumatoid Factor (RF) and sometimes Anti-CCP to screen for autoimmune joint diseases. Additionally, Uric Acid levels are frequently measured to assess for gout, a condition notably prevalent in men. By analyzing these specific biomarkers, healthcare providers can differentiate between inflammatory and non-inflammatory joint pain, facilitating an accurate diagnosis and timely intervention to preserve long-term joint health.

Back Swelling – Large Biopsy (3–6 cm)

A Back Swelling – Large Biopsy (3–6 cm) is a procedure in which a tissue sample is taken from a larger lump or swelling on the back for laboratory examination. It helps identify the exact cause, such as a benign growth, infection, inflammation, cyst, or cancer. The biopsy is usually performed under local anesthesia, making it a safe and minimally uncomfortable procedure. Accurate diagnosis allows doctors to plan the most appropriate treatment and avoid unnecessary surgery. If you notice a persistent, enlarging, or painful back swelling, consult your healthcare provider promptly for proper evaluation and timely management.

An **Aspergillosis IgM Antibodies Test** is a diagnostic blood assay designed to detect Immunoglobulin M (IgM) antibodies against the *Aspergillus* fungus. Because IgM is the first antibody produced by the immune system following exposure to an antigen, detecting Aspergillosis IgM indicates an acute or early-stage fungal infection.
This test is particularly valuable for identifying recent exposure or early invasive aspergillosis, especially in immunocompromised patients or individuals with existing lung conditions. By flagging early-stage fungal activity, the assay enables healthcare providers to initiate prompt antifungal therapies, preventing the spread of infection and protecting pulmonary function.

An **Aspartate Aminotransferase (SGOT/AST) Test** is a crucial diagnostic blood assay used to measure levels of the AST enzyme in the bloodstream. While primarily found in the liver, AST is also present in heart tissue, skeletal muscles, kidneys, and the brain.
Elevated SGOT levels typically indicate cellular injury or tissue damage, commonly resulting from liver conditions like hepatitis, cirrhosis, or fatty liver disease, as well as muscle trauma or cardiac events. Often evaluated alongside Alanine Aminotransferase (ALT), this test helps healthcare providers assess liver functionality, monitor disease progression, and determine the underlying cause of organ injury.

An **Arthritis Screen Profile (4 Markers)** is a targeted, focused diagnostic blood test designed for early evaluation of joint pain and systemic inflammation. By measuring four key biomarkers—typically **Rheumatoid Factor (RF)**, **Anti-CCP**, **C-Reactive Protein (CRP)**, and **Erythrocyte Sedimentation Rate (ESR)**—this profile helps clinicians differentiate between autoimmune disorders like rheumatoid arthritis and non-autoimmune conditions.
The test detects active inflammatory processes, identifies specific autoantibodies, and assesses overall disease severity. Swift and precise, the 4-marker panel enables healthcare providers to establish an accurate diagnosis, start timely therapeutic intervention, and help safeguard long-term joint health and mobility.

An **arthritis scan test** is a non-invasive diagnostic imaging procedure—such as an MRI, ultrasound, X-ray, or CT scan—used to evaluate joint health and detect structural changes. It provides detailed visual insights into affected joints, allowing clinicians to assess cartilage wear, bone erosion, joint space narrowing, fluid accumulation, and soft tissue inflammation.
By accurately identifying conditions like osteoarthritis, rheumatoid arthritis, or psoriatic arthritis, these scans play a critical role in confirming diagnoses. They also help monitor disease progression and evaluate treatment response over time. Timely imaging empowers healthcare providers to customize targeted therapies, protect joint functionality, and manage long-term discomfort effectively.

An **arsenic test** is a diagnostic laboratory procedure used to measure the concentration of toxic arsenic levels in the body. Healthcare providers typically order a 24-hour or spot **urine test** as the most reliable indicator of recent exposure, as inorganic arsenic clears rapidly from the bloodstream. **Blood tests** detect acute, immediate toxicity, while **hair and nail samples** reveal chronic exposure over preceding months.
Clinicians utilize these tests for individuals experiencing unexplained symptoms like abdominal pain, neuropathy, or skin changes, as well as those exposed to contaminated well water or industrial hazards.

The **Array Chrome test** (Chromosomal Microarray Analysis / Array CGH) is an advanced genetic diagnostic test used primarily to evaluate pediatric health and developmental conditions. By scanning an individual's entire genome sequence at high resolution, it identifies tiny, sub-microscopic chromosomal abnormalities—specifically copy number variations (CNVs) like microdeletions or microduplications of DNA—that traditional karyotyping misses.
Healthcare providers commonly order this blood test for children displaying developmental delays, intellectual disabilities, autism spectrum disorders, unexplained seizures, or congenital malformations. Identifying these subtle genetic changes helps clinicians pinpoint underlying medical causes, tailor personalized treatment plans, and provide informed genetic counseling to families.

A lumps and bumps biopsy is a simple medical procedure used to evaluate unusual growths, soft tissue swellings, or skin lesions. When a lump is detected under or on the skin, a tiny sample of tissue or fluid is removed for laboratory examination. Doctors typically perform this using fine-needle aspiration, core needle biopsy, or a minor surgical excision under local anesthesia. The harvested sample is then analyzed by a pathologist to determine whether the tissue is benign, inflammatory, or malignant. This essential diagnostic test provides clarity, helping your healthcare team create a safe, targeted treatment plan tailored to your needs.